[Advanced medicinal products medical therapy based on mesenchymal stem cells].
作者信息
Renata Szydlak
机构信息
Katedra Biochemii Lekarskiej, Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum, Kraków.
出版信息
Farm Pol. 2018;74(3):178-183.
Abstract
摘要
相似文献
1
[Advanced medicinal products medical therapy based on mesenchymal stem cells].
Farm Pol. 2018;74(3):178-183.
2
[Mesenchymal stromal cells in the treatment of graft-versus-host disease: where do we stand?].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1265-73. doi: 10.1007/s00103-015-2244-0.
3
GMP-grade human fetal liver-derived mesenchymal stem cells for clinical transplantation.
Methods Mol Biol. 2015;1283:123-36. doi: 10.1007/7651_2014_101.
4
The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products.
Br J Haematol. 2017 Jan;176(1):9-15. doi: 10.1111/bjh.14384. Epub 2016 Oct 17.
5
[Report from the Committee for Advanced Therapies (CAT). Pitfalls on the way from concept to medical treatment with advanced therapy medicinal products].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Jul;54(7):822-30. doi: 10.1007/s00103-011-1304-3.
6
From discovery to approval of an advanced therapy medicinal product-containing stem cells, in the EU.
Regen Med. 2016 Jun;11(4):407-20. doi: 10.2217/rme-2015-0051. Epub 2016 Apr 19.
7
Standard operating procedure for the good manufacturing practice-compliant production of human bone marrow mesenchymal stem cells.
Methods Mol Biol. 2015;1283:171-86. doi: 10.1007/7651_2014_103.
8
[Regulation (EC) No. 1394/2007 on advanced therapy medicinal products : Incorporation into national law].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Jan;53(1):14-9. doi: 10.1007/s00103-009-0985-3.
9
[Ethical aspects of human embryonic stem cell use and commercial umbilical cord blood stem cell banking. Ethical reflections on the occasion of the regulation of the European Council and Parliament on advanced therapy medicinal products].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Jan;53(1):63-7. doi: 10.1007/s00103-009-0994-2.
10
[Regulatory requirements regarding cell-based medicinal products for human and veterinary use - a comparison].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Nov;58(11-12):1299-305. doi: 10.1007/s00103-015-2247-x.
本文引用的文献
1
Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence.
Stem Cells Int. 2016;2016:4798639. doi: 10.1155/2016/4798639. Epub 2016 Sep 19.
2
Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
Adv Exp Med Biol. 2015;871:103-30. doi: 10.1007/978-3-319-18618-4_6.
3
Stem Cell Therapies in Clinical Trials: Progress and Challenges.
Cell Stem Cell. 2015 Jul 2;17(1):11-22. doi: 10.1016/j.stem.2015.06.007.
4
Standard requirement of a microbiological quality control program for the manufacture of human mesenchymal stem cells for clinical use.
Stem Cells Dev. 2014 May 15;23(10):1074-83. doi: 10.1089/scd.2013.0625. Epub 2014 Feb 20.
5
Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls.
Stem Cells Dev. 2013 Jun 15;22(12):1789-801. doi: 10.1089/scd.2012.0594. Epub 2013 Feb 25.
6
Development of a cell-based medicinal product: regulatory structures in the European Union.
Br Med Bull. 2013;105:85-105. doi: 10.1093/bmb/lds036. Epub 2012 Nov 25.
7
Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research.
Clin Exp Med. 2014 Feb;14(1):25-33. doi: 10.1007/s10238-012-0213-6. Epub 2012 Sep 27.
8
Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.
World J Stem Cells. 2010 Aug 26;2(4):81-92. doi: 10.4252/wjsc.v2.i4.81.
9
In vitro Differentiation Potential of Mesenchymal Stem Cells.
Transfus Med Hemother. 2008;35(3):228-238. doi: 10.1159/000124281. Epub 2008 May 8.
10
[The future of new therapies in clinical medicine].
Med Clin (Barc). 2011 Nov 26;137(14):645-9. doi: 10.1016/j.medcli.2010.12.005. Epub 2011 Mar 11.
Zotero 插件